ArticleHaematologica2021

Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models.

Raghuveer Singh Mali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.